Our investors empower Abzu innovation.
The support of our partners helped us to become the best in class in silico RNA Tx company.
The foundation of our future.
Driving breakthroughs in drug discovery and AI.
Abzu is an EIC Accelerator Grant recipient.
Achieving the pinnacle of EU funding.
In a remarkable endorsement of our ethical technology, European values, and commitment to unlocking the future of RNA therapeutics, Abzu has been honored with an EIC Accelerator Grant at its maximum funding capacity of €2.5 million.
Pre-seed and seed funding: The power of partnership.
Abzu has raised a total of € 10.2 million in funding.
Investment in Abzu is more than financial backing; it’s a belief in our potential to revolutionize the field of RNA therapeutics with our AI-driven approach.
Thanks to our VCs:
One of the most experienced Nordic venture funds, Inventure specializes in helping with talent and expansion.
Interested in investing in Abzu?
Then we’re interested in getting to know you.
We are discerning in our selection of investment partners. If you share our vision for unlocking the future of RNA Tx with explainable AI, then please complete the form below to start the conversation.
Entering your information above does not subscribe you to marketing emails from Abzu. It just makes it easier for us to get in touch with you. If you want to subscribe for information from Abzu, you can subscribe here.